STOCK TITAN

NeuroMetrix to Present at H.C. Wainwright BioConnect Conference 2022

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary

NeuroMetrix, Inc. (Nasdaq: NURO) announced that Dr. Shai N. Gozani, President and CEO, will present at the H.C. Wainwright BioConnect Conference from January 10-13, 2022. The presentation will be available on-demand starting January 10 at 7:00 AM (ET) for 90 days. Dr. Gozani will discuss the company's product offerings, growth initiatives, and outlook for 2022. NeuroMetrix specializes in non-invasive medical devices for diagnosing and treating pain and neurological disorders, with products like DPNCheck®, ADVANCE®, and Quell®.

Positive
  • None.
Negative
  • None.

WOBURN, Mass., Jan. 05, 2022 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq: NURO) announced today that Shai N. Gozani M.D., Ph.D., President and Chief Executive Officer, will be presenting at the H.C. Wainwright BioConnect Conference to be held virtually on January 10-13, 2022. Dr. Gozani’s video presentation will be available on-demand for 90 days starting on Monday, January 10, 2022 at 7:00 A.M. (ET). It may be accessed here and also on the NeuroMetrix, Inc. Investor Relations page at www.NeuroMetrix.com. Dr. Gozani will highlight the Company's product portfolio, growth initiatives and outlook for 2022.

About NeuroMetrix

NeuroMetrix is an innovation-driven company focused on the development and global commercialization of non-invasive medical devices for the diagnosis and treatment of pain and neurological disorders. The Company has three commercial products. DPNCheck® is a diagnostic device that provides rapid, point-of-care detection of peripheral neuropathies. ADVANCE® is a diagnostic device that provides automated, in-office nerve conduction studies for the evaluation of focal neuropathies. Quell® is a wearable neurostimulation device indicated for treatment of lower extremity chronic pain. For more information, visit www.NeuroMetrix.com/.

NeuroMetrix, Inc.
Thomas T. Higgins, 781-314-2761
SVP and Chief Financial Officer
neurometrix.ir@neurometrix.com

Source: NeuroMetrix, Inc.


FAQ

When will the NeuroMetrix presentation at the H.C. Wainwright BioConnect Conference take place?

The NeuroMetrix presentation will take place from January 10-13, 2022.

How can I access the NeuroMetrix presentation?

The presentation will be available on-demand starting January 10, 2022, at 7:00 AM (ET) for 90 days.

Who is presenting for NeuroMetrix at the conference?

Dr. Shai N. Gozani, the President and CEO of NeuroMetrix, will be presenting.

What will Dr. Gozani discuss during the presentation?

Dr. Gozani will highlight NeuroMetrix's product portfolio, growth initiatives, and 2022 outlook.

What products does NeuroMetrix offer?

NeuroMetrix offers DPNCheck®, ADVANCE®, and Quell® for diagnosing and treating pain and neurological disorders.

NeuroMetrix, Inc.

NASDAQ:NURO

NURO Rankings

NURO Latest News

NURO Stock Data

7.45M
2.04M
25.45%
2.71%
1.04%
Medical Devices
Surgical & Medical Instruments & Apparatus
Link
United States of America
WALTHAM